C-Erbb-2
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What C-Erbb-2 (HER2) Means
C-Erbb-2, also known as HER2, HER2/Neu, human EGF receptor 2, or human epidermal growth factor receptor 2, is a protein found on the surface of some cells. It plays a role in sending signals that tell cells when to grow and divide. In healthy cells, this process is carefully controlled to keep growth normal. However, in some cancers, cells produce too much HER2, which can cause them to grow faster and spread more easily.
Why HER2 Matters in Cancer Care
HER2 is most often discussed in breast cancer but can also be involved in ovarian, bladder, pancreatic, stomach, and esophageal cancers. When cancer cells have extra HER2, they are called HER2-positive or C-Erbb-2 positive. This information helps doctors understand how aggressive the cancer might be and whether treatments that specifically target HER2 could be helpful. Targeted therapies aim to block the effects of HER2, potentially slowing cancer growth or helping to kill cancer cells.
What Patients Might See or Hear About HER2
You might hear your care team say your cancer is HER2-positive or C-Erbb-2 positive. This means tests showed your cancer cells have more HER2 protein than usual. This status is often reported in pathology reports after a biopsy or surgery. It can also come up when discussing treatment plans or clinical trials. Knowing your HER2 status helps your doctors recommend the best treatment options for you.
How HER2 Testing Helps Guide Treatment
Doctors test tumor samples to check HER2 levels. This test is important because it helps decide if targeted treatments against HER2 might be effective. These treatments are designed to specifically attack cancer cells with too much HER2. HER2 testing is one part of a larger picture that doctors use to plan your care, alongside other tests and factors.
What HER2 Status Does Not Automatically Mean
Having HER2-positive cancer does not automatically mean your cancer is more dangerous or that treatment will be the same for everyone. It is one factor among many that influence treatment decisions. Not all cancers have high HER2 levels, so testing is necessary to understand each person’s unique situation.
Common Questions to Ask Your Care Team
If you hear about HER2 or C-Erbb-2 in your care, it can help to ask questions like: What does it mean that my cancer is HER2-positive? Are there treatments that target HER2? How will this affect my treatment plan and follow-up care? Your healthcare team can explain what your test results mean and how they influence your options.
Understanding Different Names for the Same Protein
You may see different names like HER2, C-Erbb-2, HER2/Neu, or human epidermal growth factor receptor 2. These all refer to the same protein. Recognizing these terms can help you follow discussions and reports without confusion.
Important Reminder About This Information
This information is educational and does not replace personalized medical advice. Each person’s cancer is unique, and treatment decisions depend on many factors. If you have questions about HER2 or how it relates to your care, talking openly with your healthcare team is the best next step. They can help you understand what your test results mean and guide you through your treatment choices.
Sources
Public source information used for this glossary entry includes: